About: http://webisa.webdatacommons.org/223052986

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	March 7 (Reuters) - Several companies are developing new, longer-acting versions of vital blood clotting factors used by people with hemophilia to prevent joint damage and other complications of the inherited bleeding disorder.
http://www.w3.org/ns/prov#wasQuotedFrom	trust.org